← Leaderboards
Sofia Diana Merajver
University Of Michigan At Ann Arbor
$3,387,621
Attributed
$4,143,300
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $388.4K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,143,300 · 6
By mechanism
R01$2,230,621 · 1
R33$1,138,128 · 1
R21$774,345 · 2
M01$206 · 2
Top collaborators
- Jianping Fu2 shared
- Matthew B Soellner2 shared
- Christopher Ryan Oliver1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- George J Brewer$2,763,501
- Susan G. Urba$225,204
- David P Ballou$5,493,094
- Catherine Cook Kaczorowski$37,630,639
- James Michael Balter$4,444,837
Others in their field
Top investigators on “Copper”
- Svetlana Lutsenko · Oregon Health And Science University$18,045,733
- Kenneth D. Karlin · Johns Hopkins University$16,339,237
- Stephen L Buchwald · Massachusetts Institute Of Technology$15,093,202
- Ninian J Blackburn · Oregon Graduate Institute Science &Tech$14,898,278
- Michael J Petris · University Of Missouri-Columbia$14,851,498
- Edward I Solomon · Stanford University$13,845,825
Research focus
CopperMolecularTumorNeoplasm MetastasisPathway InteractionsMetastasisAngiogenesis InhibitorsIn VivoNeoplastic CellPreventionBreast NeoplasmsGrantPreventCancer CellPredictive MarkerScid MouseMouse ModelMalignant NeoplasmsLaboratory MouseLesionDisease /Disorder ModelIn VitroFutureMalignant Breast Neoplasm
Grant awards (18)
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence$369,018
R33 · FY2024 · CA · contact PI
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence$380,672
R33 · FY2023 · CA · contact PI
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence$388,438
R33 · FY2022 · CA · contact PI
Artificial Intelligence driven prediction of brain metastasis from primary tumor sites at diagnosis$182,325
R21 · FY2021 · CA · contact PI
Artificial Intelligence driven prediction of brain metastasis from primary tumor sites at diagnosis$218,790
R21 · FY2020 · CA · contact PI
Integrative signaling to increase efficacy of targeted therapies for triple negative breast cancer$169,650
R21 · FY2018 · CA · contact PI
Integrative signaling to increase efficacy of targeted therapies for triple negative breast cancer$203,580
R21 · FY2017 · CA · contact PI
Prevention of Mammary Cancer in Her-2neu Transgenic Mice$265,557
R01 · FY2007 · CA · contact PI
Prevention of Mammary Cancer in Her-2neu Transgenic Mice$273,703
R01 · FY2006 · CA · contact PI
Prevention of Mammary Cancer in Her-2neu Transgenic Mice$362,537
R01 · FY2005 · CA
Prevention of Mammary Cancer in Her-2neu Transgenic Mice$280,712
R01 · FY2004 · CA
Prevention of Mammary Cancer in Her-2neu Transgenic Mice$280,914
R01 · FY2003 · CA
PREVENTION OF MAMMARY CANCER IN HER-2NEU TRANSGENIC MICE$237,244
R01 · FY2002 · CA
STUDY OF TETRATHIOMOLYBDATE (TM) AS A DECOPPERING AND ANTIANGIOGENESIS OF CANCER$0
M01 · FY2002 · RR
PREVENTION OF MAMMARY CANCER IN HER-2NEU TRANSGENIC MICE$268,349
R01 · FY2001 · CA
PREVENTION OF MAMMARY CANCER IN HER-2NEU TRANSGENIC MICE$261,605
R01 · FY2000 · CA
FAMILIES WITH GENETIC SUSCEPTIBILITY TO BREAST CANCER$206
M01 · FY2000 · RR
STUDY OF TETRATHIOMOLYBDATE (TM) AS A DECOPPERING AND ANTIANGIOGENESIS OF CANCER$0
M01 · FY2000 · RR